Insufficient scRNA-seq data for expression of ACKR4 at single-cell level.
Insufficient scRNA-seq data for expression of ACKR4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 92% | 277.71 | 424 / 459 | 65% | 2.07 | 731 / 1118 |
pancreas | 63% | 61.73 | 205 / 328 | 84% | 3.42 | 149 / 178 |
lung | 99% | 227.75 | 571 / 578 | 43% | 1.73 | 501 / 1155 |
stomach | 84% | 168.45 | 303 / 359 | 55% | 4.24 | 157 / 286 |
esophagus | 55% | 81.71 | 794 / 1445 | 71% | 3.47 | 130 / 183 |
skin | 98% | 547.97 | 1770 / 1809 | 25% | 0.87 | 118 / 472 |
uterus | 78% | 209.21 | 133 / 170 | 38% | 2.39 | 173 / 459 |
intestine | 76% | 108.40 | 730 / 966 | 37% | 1.77 | 194 / 527 |
kidney | 36% | 32.64 | 32 / 89 | 74% | 2.93 | 664 / 901 |
bladder | 71% | 106.00 | 15 / 21 | 34% | 1.16 | 172 / 504 |
blood vessel | 90% | 336.42 | 1205 / 1335 | 0% | 0 | 0 / 0 |
adipose | 88% | 401.69 | 1054 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 75% | 64.55 | 194 / 258 | 7% | 0.14 | 15 / 230 |
heart | 80% | 141.78 | 689 / 861 | 0% | 0 | 0 / 0 |
ovary | 44% | 36.65 | 79 / 180 | 30% | 1.10 | 129 / 430 |
thymus | 60% | 69.95 | 395 / 653 | 11% | 0.19 | 68 / 605 |
spleen | 63% | 47.98 | 153 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 47% | 2.52 | 21 / 45 |
lymph node | 0% | 0 | 0 / 0 | 24% | 0.61 | 7 / 29 |
brain | 1% | 0.59 | 26 / 2642 | 17% | 0.34 | 118 / 705 |
prostate | 16% | 11.12 | 40 / 245 | 1% | 0.04 | 7 / 502 |
liver | 8% | 5.17 | 19 / 226 | 3% | 0.12 | 14 / 406 |
peripheral blood | 6% | 4.00 | 57 / 929 | 0% | 0 | 0 / 0 |
muscle | 5% | 4.55 | 43 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0070098 | Biological process | chemokine-mediated signaling pathway |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0006935 | Biological process | chemotaxis |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0060326 | Biological process | cell chemotaxis |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005769 | Cellular component | early endosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0055037 | Cellular component | recycling endosome |
GO_0016493 | Molecular function | C-C chemokine receptor activity |
GO_0019957 | Molecular function | C-C chemokine binding |
GO_0004950 | Molecular function | chemokine receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0005044 | Molecular function | scavenger receptor activity |
Gene name | ACKR4 |
Protein name | Atypical chemokine receptor 4 (C-C chemokine receptor type 11) (C-C CKR-11) (CC-CKR-11) (CCR-11) (CC chemokine receptor-like 1) (CCRL1) (CCX CKR) Atypical chemokine receptor 4 |
Synonyms | CCRL1 CCBP2 VSHK1 CCR11 |
Description | FUNCTION: Atypical chemokine receptor that controls chemokine levels and localization via high-affinity chemokine binding that is uncoupled from classic ligand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis. Also known as interceptor (internalizing receptor) or chemokine-scavenging receptor or chemokine decoy receptor. Acts as a receptor for chemokines CCL2, CCL8, CCL13, CCL19, CCL21 and CCL25. Chemokine-binding does not activate G-protein-mediated signal transduction but instead induces beta-arrestin recruitment, leading to ligand internalization. Plays an important role in controlling the migration of immune and cancer cells that express chemokine receptors CCR7 and CCR9, by reducing the availability of CCL19, CCL21, and CCL25 through internalization. Negatively regulates CXCR3-induced chemotaxis. Regulates T-cell development in the thymus. . |
Accessions | H0Y9Z2 ENST00000249887.3 Q9NPB9 ENST00000509820.1 |